Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

BUY
$183.43 - $232.67 $3,852 - $4,886
21 Added 1.68%
1,270 $238,000
Q1 2023

Apr 07, 2023

BUY
$193.75 - $232.55 $42,625 - $51,161
220 Added 21.38%
1,249 $290,000
Q4 2022

Feb 02, 2023

SELL
$187.24 - $242.74 $12,919 - $16,749
-69 Reduced 6.28%
1,029 $208,000
Q3 2022

Oct 12, 2022

SELL
$177.23 - $227.44 $3,544 - $4,548
-20 Reduced 1.79%
1,098 $209,000
Q2 2022

Jul 27, 2022

BUY
$181.58 - $368.0 $44,123 - $89,424
243 Added 27.77%
1,118 $206,000
Q1 2022

Apr 25, 2022

BUY
$303.87 - $423.8 $66,851 - $93,236
220 Added 33.59%
875 $306,000
Q4 2021

Feb 11, 2022

BUY
$347.28 - $421.83 $32,991 - $40,073
95 Added 16.96%
655 $249,000
Q3 2021

Nov 05, 2021

SELL
$405.61 - $524.84 $10,951 - $14,170
-27 Reduced 4.6%
560 $227,000
Q2 2021

Aug 10, 2021

SELL
$372.84 - $481.5 $23,861 - $30,816
-64 Reduced 9.83%
587 $278,000
Q1 2021

May 10, 2021

BUY
$361.28 - $504.76 $361 - $504
1 Added 0.15%
651 $250,000
Q4 2020

Jan 19, 2021

BUY
$292.7 - $370.96 $190,255 - $241,124
650 New
650 $240,000
Q2 2020

Aug 03, 2020

SELL
$256.46 - $373.01 $1.8 Million - $2.61 Million
-7,005 Closed
0 $0
Q4 2019

Jan 21, 2020

SELL
$288.29 - $335.49 $25,369 - $29,523
-88 Reduced 1.24%
7,005 $2.32 Million
Q3 2019

Oct 16, 2019

SELL
$266.84 - $378.23 $3,468 - $4,916
-13 Reduced 0.18%
7,093 $2.16 Million
Q2 2019

Aug 09, 2019

SELL
$300.59 - $368.15 $56,510 - $69,212
-188 Reduced 2.58%
7,106 $2.62 Million
Q1 2019

May 14, 2019

BUY
$272.57 - $321.18 $20,442 - $24,088
75 Added 1.04%
7,294 $2.27 Million
Q4 2018

Feb 08, 2019

SELL
$272.46 - $366.54 $1.47 Million - $1.98 Million
-5,400 Reduced 42.79%
7,219 $2.17 Million
Q3 2018

Nov 01, 2018

BUY
$279.04 - $367.06 $3.52 Million - $4.63 Million
12,619 New
12,619 $4.63 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Mission Wealth Management, LP Portfolio

Follow Mission Wealth Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mission Wealth Management, LP with notifications on news.